Quality Systems, Inc. to Present at Oppenheimer & Co. 22nd Annual Healthcare Conference

Published on Thursday, 08 December 2011 17:25 Written by TradersHuddle Staff

IRVINE, Calif.-( Business Wire )-

Quality Systems, Inc. (NASDAQ: QSII) announced today that its management plans to present its corporate story at the upcoming Oppenheimer & Co. 22^nd Annual Healthcare Conference.

The conference, which will showcase 150 public and private companies within the pharmaceutical, biotechnology, medical device, healthcare facility, health technology and distribution, provider and service industries, for institutional investors, is scheduled for Tuesday, December 13 - Wednesday, December 14, 2011 at the Waldorf=Astoria in New York City. Quality Systems’ Chief Executive Officer Steven T. Plochocki is scheduled to present on Wednesday, December 14 at 10:50 A.M. local time. The presentation will address the company’s operations and strategy. Each participating company is scheduled for a 30-minute presentation, including a question and answer session.

A webcast of Quality Systems’ audio presentation will be available on Wednesday, December 14 (beginning at the start time of the presentation) and can be viewed by accessing http://www.veracast.com/webcasts/opco/healthcare2011/45207277.cfm. It will be archived for 90 days.

Oppenheimer & Co. Inc. (NYSE:OPY) is a leading investment bank and full-service investment firm that provides financial services and advice to high net worth investors, individuals, businesses and institutions.

About Quality Systems, Inc.

Irvine, Calif.-based Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. Visit www.qsii.com and www.nextgen.com for additional information.

SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; general economic conditions; and the risk factors detailed from time to time in the Company’s periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Quality Systems, Inc.Susan J. Lewis, This e-mail address is being protected from spambots. You need JavaScript enabled to view it.